U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Guidance, Compliance, & Regulatory Information
  4. Human Drug Compounding
  5. Registered Outsourcing Facilities
  1. Human Drug Compounding

Registered Outsourcing Facilities

Facilities Registered as Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act)

Updated as of 1/16/2025

This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.

FacilityContactInitial Registration Date 1Most Recent Registration Date 1Last Inspection 2Form 483 Issued? 3Recall Conducted? 9Action Based on Last Inspection 4,5Intends to Compound Sterile Drugs From Bulk Substances 6
Advanced Pharmacteutical Technology, Inc., Elmsford, NYMarco Persichillo
1-914-358-5260
8/19/20248/19/2024Not yet inspectedN/AN/AN/AYes
AH Nutraceutical Compounding, Inc., McQueeny, TXMichael Chase
312-401-7455
7/8/20247/8/2024Not yet inspectedN/AN/AN/AYes
AnazaoHealth Corporation, Las Vegas, NVJaclyn Wong
800-995-4363
Ext 3120
9/23/201412/10/20249/23/2024YesNoOpen7Yes
Annovex Pharma, Inc., Lorton, VAAdedayo Akinbi
1-571-642-5104   
10/14/202111/22/20249/6/2024Yes NoOpenYes
Apocus, Inc., San Antonio, TXSuryanarayana Raju Sagi
214-797-7172
10/17/202310/17/2023Not yet inspectedN/AN/AN/AYes
Apollo Care, Columbia, MOJarred Dudding
573-441-8900
9/14/201712/16/20244/5/2023YesYesRegulatory Meeting Held 11/30/2023Yes
Apothecary Pharma, LLC, Cary, NCPriyanka Rana 1-919-760-54789/7/20241/11/2025Not yet inspectedN/A N/A N/A Yes
Arc Compounding Pharmacy LLC, Waco, TXClifton King
512-665-6911
6/22/20246/22/2024Not yet inspectedN/AN/AN/AYes
Assure Infusions, Inc., Bartow, FLGloria Imbimbo
1-386-451-2673
11/22/202411/22/2024Not yet inspectedN/AN/AN/ANo
Atlas Pharmaceuticals, LLC, Phoenix, AZMichael Papenthien
480-349-2233
11/8/201711/10/20235/21/2021YesNoFMD-145 Letter Issued 5/3/2022Yes
Aveva Drug Delivery Systems, Inc, Tamarac, FLMadhuri Gupta 1-954-218-157011/4/202411/4/2024Not yet inspectedN/AN/AN/AYes
BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy, Temple Terrace, FLKenneth Jozefczyk
813-901-6339
6/4/201910/25/20246/2/2023YesNoFMD-145 Letter Issued 9/18/2023No
Belcher Pharmaceuticals, LLC, Largo, FLShyam Busireddy
727-471-0850
Ext 239
5/18/202110/18/20248/16/2024YesNoOpenNo
Bennett Pharmaceuticals of AmericaLLC, Hudson, WIJames Mulvahill
952-381-9027
4/19/20221/19/2024Not yet inspectedN/AN/AN/AYes
BPI Labs LLC, Largo, FLChandra Kasireddy
727-471-0850
3/4/201910/17/20244/30/2021NoNoFMD-145 Letter Issued 9/10/2021Yes
Brookfield Medical/Surgical Supply, Inc., Brookfiled, CTJames Cangelosi
203-775-0862
1/12/20151/10/20255/10/2024YesNoUntitled Letter Issued 9/27/2024Yes
BSO LLC, Golden, COMichelle Violi
608-221-7800
Ext 1113
1/24/202410/18/2024Not yet inspectedN/AN/AN/AYes
BSO LLC, Lakewood, COMichelle Violi
608-221-7800
Ext 1113
11/24/201510/31/20247/3/2024YesNoOpen7Yes
C S Bio Co., Menlo Park, CAJason Yowei Chang
650-322-1111
5/23/20245/23/2024Not yet inspectedN/AN/AN/AYes
Central Admixture Pharmacy Services, Inc., Allentown, PAEric Bauer 1-551-204-41782/28/201410/22/20243/30/2023YesYesWarning Letter Issued 3/29/2024Yes
Central Admixture Pharmacy Services, Phoenix, AZEric Bauer 1-551-204-41783/29/201810/22/20247/31/2023YesYesWarning Letter Issued 3/25/2024Yes
Delta Pharma, Inc., Ripley, MSStuart Simpson
662-512-5191
8/6/201412/31/20244/12/2024YesNoOpen7Yes
Denver Solutions, LLC, dba Leiters Health, Englewood, COBarbara Knightly
720-697-5140
Ext 4004
3/24/201711/18/20244/5/2024YesNoFMD-145 issued 11/20/24Yes
Denver Solutions, LLC, dba Leiters Health, Buena, NJBarbara Knightly
720-697-5140
Ext 4004
7/1/202211/18/2024Not yet inspectedN/AN/AN/AYes
Eagle Pharma, Birmingham, ALHaleigh Cawood
205-682-7999
6/16/201510/23/20248/12/2021YesNoUntitled Letter Issued 5/17/2022Yes
Echo Health LLC dba Nova Specialty Pharmacy, Mansfield, TXObiechina Ezekwesili +1-682-267-85865/20/20245/20/2024Not yet inspectedN/A N/A N/AYes
Empower Clinic Services New Jersey, East Windsor, NJShaun Noorian
877-562-8577
6/10/202411/20/2024Not yet inspectedN/AN/AN/AYes
Empower Pharma, Houston, TXShaun Noorian
877-562-8577
7/16/201612/6/20248/28/2024YesNoOpen7Yes
Excite Pharma Services, LLC, Tonganoxie, KSRobert Pendland
816-389-8402
6/1/202112/28/2023Not yet inspectedN/AN/AN/AYes
F.H. Investments, Inc., dba Asteria Health, Birmingham, ALChristopher S. Musser
1-205-995-0505 
5/18/201710/17/202411/8/2024YesNoFMD-145 Letter Issued 9/10/2021Yes
Fagron Compounding Services dba Fagron Sterile Services, Wichita, KSJosh Parks
316-773-0405
10/2/201510/18/20246/28/2024YesNoOpen7Yes
Farmakeio Outsourcing LLC, Southlake, TXCody Boatman
817-203-8216
12/12/201812/6/20246/10/2022YesNoRegulatory Meeting Held 1/31/2023Yes
Fresenius Kabi Compounding LLC dba Fagron Sterile Services, Canton, MADeborah McHugh
316-773-0405
4/21/201710/18/202403/06/2023YesNoFMD-145 Letter Issued 08/11/2023No
GFC Pharma, LLC, Westminster, MDRanjeesh Gopinathan
215-264-9995
12/16/202412/16/2024Not yet inspectedN/AN/AN/AYes
Hikma Injectables USA Inc., Dayton, NJJ. Barton Kalis
856-489-2247
9/15/202112/20/20246/25/2024YesNoOpen7No
Hikma Pharmaceuticals USA Inc., Cherry Hill, NJJ. Barton Kalis
856-489-2247
9/15/202110/27/20236/12/2024YesNoFMD-145 Letter Issued 12/18/2024Yes
Hybrid Pharma, LLC, Deerfield Beach, FLPonswamy Rajalingam
954-708-2771
1/14/20151/8/202511/9/2023YesNoOpen7Yes
Imprimis NJOF, LLC, Ledgewood, NJFred Weiss
973-328-8756
Ext=5411
11/12/201610/23/20244/3/2024YesNoOpen7Yes
IntegraDose Compounding Services, LLC, Minneapolis, MNCraig Else
612-672-5216
5/8/201812/13/20243/1/2024YesNoOpen7No
Leesar Inc., Fort Myers, FLMaria Gautier
239-939-8925
4/30/201412/19/202410/29/2021YesNoUntitled Letter Issued 6/17/2022No
Mark Cuban Cost Plus Manufacturing and Compounding, LLC, Dallas, TXAlexander Oshmyansky
303-907-8003
11/2/202212/14/20249/6/2024YesNoOpenYes
McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing Solutions, Santa Ana, CAJacqueline McKay
714-918-7277
Ext 314
1/11/202311/21/2024Not yet inspectedN/AN/AN/AYes
Medi-Fare Drug, Blacksburg, SCAnne-Marie Davis
864-839-6500
12/17/201312/24/20245/26/2023YesNoFMD-145 Letter Issued 10/23/2023Yes
MedisourceRx, Los Alamitos, CAVenus Firouzehee
714-455-1300
2/14/201712/31/202411/10/2022NoNoFMD-145 Letter Issued 4/14/2023Yes
Molecular PharmaGroup, New Providence, NJAmanda Lanze
908-588-3440
5/8/201812/10/202412/11/2023YesNoFMD-145 Issued 3/18/2024Yes
Nephron Sterile Compounding Center, LLC (NSCC), West Columbia, SCLou Wood Kennedy
803-569-3110
7/15/201411/25/20249/25/2024YesYesOpen7Yes
Nubratori, Inc., Torrance, CAGulshakar Khwaja
310-218-4153
2/24/201710/22/20247/26/2024YesNoOpen7Yes
Olympia Pharmaceuticals, Orlando, FLMark Mikhael  
1-407-673-2222 
3/10/201410/18/20245/29/2024YesNoOpen7Yes
OSRX, Inc., Missoula, MTAmy Frost
406-541-6121
10/28/202310/25/202410/25/2024YesNoOpenYes
OurPharma LLC, Fayetteville, ARMorgan Strickland
479-313-8200
3/15/201911/14/20249/27/2024YesNoOpen7Yes
Park Avenue Compounding, St. Louis, MOKristina Bryowsky
314-989-2843
12/23/202311/8/2024Not yet inspectedN/AN/AN/ANo
PGRrx LLC, Exton, PA Amit Gupta 1-484-883-759712/10/202412/10/2024Not yet inspectedN/AN/AN/AYes
Pine Pharmaceuticals, LLC, Tonawanda, NYAlfonse Muto
716-248-1025
3/9/201810/16/20249/30/2024YesNoOpen7Yes
Pharmacorr Sterile, LLC, Oklahoma City, OKEti Garcia
1-833-327-9567
9/16/20249/16/2024Not yet inspectedN/AN/AN/AYes
PQ Pharmacy LLC, Brooksville, FLAngela Kassay
352-477-8977
10/29/202011/26/202410/27/2022YesNoFMD-145 Letter Issued 3/30/2023Yes
ProRx LLC, Exton, PAMark L'Hommedieu
1-904-616-7355
4/27/202211/22/20248/2/2024YesNoWarning Letter Issued 12/20/2024Yes
Qualgen LLC, Edmond, OKShaun Riney
405-551-8216
5/23/201411/15/20243/19/2024YesNoOpen7Yes
Quantum Pharmaceuticals, LLC, Mounds, OKAlbert Sanchez
479-263-2690
Ext 3062138
5/30/20245/30/2024Not yet inspectedN/AN/AN/AYes
Quva Pharma, Inc., Bloomsbury, NJKevin White
1-908-388-1079
9/15/201711/22/202410/14/2022YesNoWarning Letter Issued 1/26/2024Yes
Quva Pharma, Inc., Sugar Land, TXSophia Flores
1-832-500-7450
9/10/201512/9202410/28/2024YesNoOpen7Yes
Rapha Phrmaceuticals, lnc., Tampa, FLHector Molina 
1-407-362-7638
12/23/202412/23/2024Not yet inspectedN/AN/AN/AYes
RC Outsourcing, LLC, Lowellville, OHRaymond R. Carlson
330-770-6156
10/6/201511/22/20249/27/2024YesNoOpen7Yes
Right Value Drug Stores, LLC, dba Carie Boyd's Prescription Shop, Irving, TXSara Lange
817-282-9376
7/3/201912/23/20246/21/2024YesNoWarning Letter Issued 12/17/2024Yes
SCA Pharmaceuticals, Little Rock, ARKarmen Kelly
877-550-5059
12/13/201312/23/20245/17/2023Yes FMD-145 Letter Issued 9/29/2023Yes
SCA Pharmaceuticals, Windsor, CTJoanna DiStefano
877-550-5059
8/3/201712/9/202410/20/2023Yes
Yes
 Open7Yes
Signature Rx, Delray Beach, FLDavid Hughes
401-249-1963
10/13/20231/9/2025Not yet inspectedN/AN/AN/AYes
SKNV formerly registered as Sincerus Florida, LLC, Pompano Beach, FLMichael Morelli
800-604-5032
Ext 313
3/10/201611/22/20245/23/2024YesNoOpen7Yes
STAQ Pharma, Inc., Denver, COMark Spiecker
1-303-921-5789
2/5/201911/19/20249/29/2021YesNoFMD-145 Letter Issued 3/25/2022Yes
STAQ Pharma of Ohio, LLC, Columbus, OHPatrick Welsh
1-440-384-0676
1/26/202311/19/202410/4/2023YesNoFMD-145 Letter Issued 3/20/2024Yes
Staska Pharmaceuticals, Inc., Bennet, NELyndon Leitner
402-782-2207
12/3/202012/18/20249/18/2024YesNoOpenYes
Stokes Healthcare Inc., dba Epicur Pharma, Mt. Laurel, NJMichael Tursi
888-508-5032
1/30/201810/16/202410/25/2023YesNoWarning Letter Issued 4/2/2024Yes
Tailstorm Health Inc., Chandler, AZMitexh Gandhi
480-274-8617
10/23/201912/10/20247/21/2021YesNoFMD-145 Letter Issued 10/23/2023Yes
Tailstorm Health Inc., Phoenix, AZMitexh Gandhi
480-274-8617
10/23/201912/18/202410/10/2024YesNoOpenYes
Tomorrowmed Pharma, LLC, Morrisville, NCSean Hatfield
+1-919-747-3222
11/22/202411/22/2024Not yet inspectedN/AN/AN/AYes
Turbare Manufacturing, Conway, ARDeketric Smith
501-504-6635
6/23/20231/2/2024Not yet inspectedN/AN/AN/AYes
University of Tennessee, Memphis, TNHarry Kochat
901-448-1440
5/19/202412/12/2024Not yet inspectedN/AN/AN/AYes
US Specialty Formulations LLC, Allentown, PAKyle Flanigan
610-849-5023
1/31/201411/14/20246/28/2024YesNoOpen7Yes
Vitae Enim Vitae Scientific, Inc., San Diego, CABoris Gites
858-222-0746
1/2/20241/2/2024Not yet inspectedN/AN/AN/ANo
VitalRx Pharmacy, LLC, Houston, TXLinda Sarpong
832-259-1362
8/27/202412/31/2024Not yet inspectedN/AN/AN/AYes
Vivasor, San Diego, CAMark Brunswick
1-858-652-0084
10/31/202410/31/2024Not yet inspectedN/A  N/A    N/AYes
Wedgewood Connect, LLC, formerly registered as Leiter's Compounding, San Jose, CAPaul Yamamoto
408-687-0943
1/31/201410/16/202411/17/2023YesNoUntitled Letter Issued 4/25/2024Yes
Wedgewood Connect Ohio, LLC, Albany, OHAndrea Murray
1-877-357-6613
10/19/202311/7/2024Not yet inspectedN/AN/AN/AYes
Wells Pharma of Houston, LLC, Houston, TXLisa Hawkins
1-423-621-2588
3/9/202011/5/202412/14/2022YesNoFMD-145 Letter Issued 4/18/2023Yes
Wells Pharmacy, Inc., Dyersburg, TNMelissa Stefko
800-622-4510
6/7/201610/24/20241/28/2021YesNoUntitled Letter Issued 5/19/2022Yes
Willowbend Pharma Select, LLC, Houston, TXBasil Raad
832-628-3260
4/11/202411/5/2024Not yet inspectedN/AN/AN/AYes
World Reach Pharma, LLC, Albany, NYJim Pesoli
1-847-721-8122
1/26/20241/26/2024Not yet inspectedN/AN/AN/AYes
Xenith Pharmaceutical, Las Vegas, NVSamantha Koegel
516-761-1433
1/2/20251/2/2025Not yet inspectedN/AN/AN/AYes
Xseer Pharmaceuticals, Inc., Los Angeles, CAAli Khosrovni
310-606-0146
10/21/202311/27/2024Not yet inspectedN/AN/AN/AYes

Notes

  1. The "initial date of registration as an outsourcing facility" is the date the facility was first registered (i.e., the date FDA determined that the initial registration information submitted for the facility was complete, and the establishment fee was paid in full).

    Under section 503B(b) of the FD&C Act, after the initial registration, a facility that elects to continue to be registered with FDA as an outsourcing facility must re-register annually. A facility that elects to register (or re-register) with FDA as an outsourcing facility must pay an annual establishment fee. The “date of most recent registration as an outsourcing facility” reflects the date FDA determined the most recently submitted registration information was complete and the annual establishment fee for that fiscal year paid in full.

    Unless a previously registered outsourcing facility re-registers and pays the annual establishment fee in full during the registration period (between October 1 and December 31 of each calendar year), the facility will be removed from the list of registered outsourcing facilities on January 1 of the next calendar year.
  2. Once an outsourcing facility is registered, the facility will be added to the list of facilities FDA intends to inspect according to a risk-based schedule. FDA plans to inspect outsourcing facilities within a reasonable period of time following initial registration, once it is confirmed that the facility has initiated drug production and distribution. However, the exact timing of the inspections can be affected by a number of variables, including the number of outsourcing facility registrants, other inspection priorities, and the operational status of the newly registered outsourcing facility.

    Inspections identified in this table are associated with the facility at the listed address. A company may own or operate more than one registered outsourcing facility. FDA’s web page Compounding: Inspections, Recalls, and other Actions may contain information about compounding facilities under the same ownership as the listed registered outsourcing facility.

    Inspections may take place over several days, weeks or longer. The date of the inspection is the date a Form FDA 483 listing the investigators’ observations was issued. If no FDA Form 483 was issued, the date is the last day of the inspection.
  3. A Form FDA 483 is issued when investigators observe any significant objectionable conditions. It does not constitute a final agency determination of whether any condition is in violation of the FD&C Act or any relevant regulations.
  4. This table does not include State Board of Pharmacy actions, if any. To determine whether a registered outsourcing facility has been the subject of a state enforcement action, check with the State Board of Pharmacy for the state in which the facility is located. Some states post disciplinary or other actions on their web sites.
  5. “Closed” means the inspection has been closed without further action. “Open” means FDA has not determined whether further action will be taken. If an action has been taken, it will be listed. Possible FDA actions include warning letter, seizure or injunction.
  6. The information in this column was provided by the registered outsourcing facility at the time of registration and has not been verified by FDA. “N/A” indicates the registered outsourcing facility has not provided this information.
  7. This outsourcing facility was the subject of at least one previous inspection relating to compounding that resulted in a Form FDA 483, warning letter or other action. For information about such inspections and resulting actions, visit Compounding: Inspections, Recalls, and other Actions.
  8. A remote regulatory assessment (RRA) is an examination of an FDA-regulated establishment and/or its records, conducted remotely, to evaluate compliance with applicable FDA requirements. These assessments assist in protecting human and animal health, inform regulatory decisions and verify certain information submitted to the agency.
  9. Based on inspectional findings, the inspection revealed significant issues. As a result, the outsourcing facility may have either initiated a recall on their own following conversation(s) with the FDA investigator or FDA recommended a recall at the conclusion of the inspection or both. Additionally, the outsourcing facility may have conducted multiple recalls or recalled multiple drugs.

SUBSCRIBE

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top